Log in to save to my catalogue

The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Ca...

The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1159_000530991

The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib

About this item

Full title

The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Oncology, 2023-08, Vol.101 (8), p.491-501

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Introduction: Measurements of body composition, such as the skeletal muscle index (SMI), are useful for predicting prognosis in hepatocellular carcinoma (HCC). This study aimed to analyze the relationship between skeletal muscle changes during therapy with atezolizumab plus bevacizumab (Atezo + Beva) or lenvatinib (Len) and the association between...

Alternative Titles

Full title

The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_citationtrail_10_1159_000530991

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1159_000530991

Other Identifiers

ISSN

0030-2414

E-ISSN

1423-0232

DOI

10.1159/000530991

How to access this item